AU7318494A - Confirmatory assay and reagents for hepatitis e virus - Google Patents

Confirmatory assay and reagents for hepatitis e virus

Info

Publication number
AU7318494A
AU7318494A AU73184/94A AU7318494A AU7318494A AU 7318494 A AU7318494 A AU 7318494A AU 73184/94 A AU73184/94 A AU 73184/94A AU 7318494 A AU7318494 A AU 7318494A AU 7318494 A AU7318494 A AU 7318494A
Authority
AU
Australia
Prior art keywords
hepatitis
virus
reagents
confirmatory assay
confirmatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73184/94A
Inventor
George J. Dawson
Robin A. Gutierrez
Mark F Knigge
Deborah A Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU7318494A publication Critical patent/AU7318494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
AU73184/94A 1993-07-09 1994-06-28 Confirmatory assay and reagents for hepatitis e virus Abandoned AU7318494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8987793A 1993-07-09 1993-07-09
US089877 1993-07-09
PCT/US1994/007280 WO1995002070A1 (en) 1993-07-09 1994-06-28 Confirmatory assay and reagents for hepatitis e virus

Publications (1)

Publication Number Publication Date
AU7318494A true AU7318494A (en) 1995-02-06

Family

ID=22220029

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73184/94A Abandoned AU7318494A (en) 1993-07-09 1994-06-28 Confirmatory assay and reagents for hepatitis e virus

Country Status (4)

Country Link
JP (1) JPH08512406A (en)
AU (1) AU7318494A (en)
CA (1) CA2166698A1 (en)
WO (1) WO1995002070A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4475803B2 (en) * 1997-10-15 2010-06-09 アボット・ラボラトリーズ Methods and compositions for detecting hepatitis E virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV

Also Published As

Publication number Publication date
CA2166698A1 (en) 1995-01-19
WO1995002070A1 (en) 1995-01-19
JPH08512406A (en) 1996-12-24

Similar Documents

Publication Publication Date Title
EP0745128B8 (en) Hepatitis b virus mutants, reagents and methods for detection
AU5285899A (en) Anti hepatitis c virus antibody and uses thereof
AU1566595A (en) Method and reagent for inhibiting hepatitis c virus replication
AU6404394A (en) Assays and therapeutic methods based on lymphocyte chemoattractants
AU666605B2 (en) Reagent for endotoxin assay and method for endotoxin assay using the same
AU7440394A (en) Reagent for endotoxin-specific assay
AU6700598A (en) Intron-mediated recombinant techniques and reagents
AU8173098A (en) Neuroprotective methods and reagents
AU1322095A (en) Method of assay using two distinguishable types of particles
AU1186695A (en) Reagents and methods for the detection of methotrexate
AU5325594A (en) Protein partner screening assays and uses thereof
AU1448295A (en) Assay employing both protein and antibody
AU3900893A (en) Quantitative viral assay
GB9320562D0 (en) Novel assay and applications
AU4159697A (en) Interaction trap assay, reagents and uses thereof
AU5905094A (en) Nucleic acid assay procedure
AU7318494A (en) Confirmatory assay and reagents for hepatitis e virus
GB9710875D0 (en) Assay for detecting HIV antigens and HIV antibodies
AU3394995A (en) Bioluminescence and assay reagents
AU7819494A (en) Assay method
AU5851494A (en) Serum pyridinium crosslinks assay
AU4937093A (en) Conjugate for the detection and/or assay of a biological compound
AU7541894A (en) Cell reagent and assay
AU6769594A (en) Hepatitis c virus immunodiagnostic antigens and antibodies
AU6146994A (en) Selective binding materials and assays